Get started today

Psychosis & Medicinal Cannabis

Presented by Dr Philip Blair, MD

About this module:

In this presentation by experienced medicinal cannabis clinician Dr Philip Blair MD (US), the conditions of depression and psychosis are discussed and six case studies presented to illustrate Dr Blair’s treatment approaches. This presentation is targeted at healthcare practitioners and assumes a knowledge of the endocannabinoid system and the pharmacodynamics of medicinal cannabis. 
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe the signs and symptoms associated with the cycle of depression.
  • Argue why inflammation may be important in the pathophysiology of depression.
  • Debate the evidence of involvement of the endocannabinoid system in the relationship between depression and pain.
  • Explain the why omega-3 fatty acids are important in relation to depression and suicide risk.
  • Formulate strategies for the treatment of depression using medicinal cannabis products and relevant dietary advice.

Dr Philip Blair, MD

Dr. Philip Blair, MD, (Colonel, US Army, retired) is a Family Physician and consultant in disease management in the Northwest USA. He graduated from West Point in 1972, attended the University of Miami School of Medicine, training as an Army Family Physician and serving as a combat physician in the first Gulf War. After medical assignments in three continents and 29 years in uniform, he retired from the Army and has been consulting on complex disease management since 2000.
Dr. Blair has been studying, treating, and lecturing about the human body’s natural endocannabinoid system (ECS) since 2014. His goal is to restore health and performance by enhancing the ECS using diet, exercise, appropriate medications and non-psychoactive therapies.
Created with